Cargando…
Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome
BACKGROUND: Crohn’s disease (CD) patients demonstrate distinct intestinal microbial compositions and metabolic characteristics compared to unaffected controls. However, the impact of inflammation and underlying genetic risk on these microbial profiles and their relationship to disease phenotype are...
Autores principales: | Jacobs, Jonathan P., Goudarzi, Maryam, Lagishetty, Venu, Li, Dalin, Mak, Tytus, Tong, Maomeng, Ruegger, Paul, Haritunians, Talin, Landers, Carol, Fleshner, Philip, Vasiliauskas, Eric, Ippoliti, Andrew, Melmed, Gil, Shih, David, Targan, Stephan, Borneman, James, Fornace, Albert J., McGovern, Dermot P. B., Braun, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377146/ https://www.ncbi.nlm.nih.gov/pubmed/35971134 http://dx.doi.org/10.1186/s13073-022-01099-7 |
Ejemplares similares
-
Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphism
por: Tong, Maomeng, et al.
Publicado: (2014) -
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients
por: Jacobs, Jonathan P., et al.
Publicado: (2016) -
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships
por: McHardy, Ian H, et al.
Publicado: (2013) -
Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn’s disease
por: Potdar, Alka A., et al.
Publicado: (2020) -
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
por: Liu, Ruize, et al.
Publicado: (2023)